James B. Bucher - Dec 21, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Legal Officer
Signature
/s/ James B. Bucher
Stock symbol
HARP
Transactions as of
Dec 21, 2023
Transactions value $
$0
Form type
4
Date filed
12/26/2023, 04:10 PM
Previous filing
Nov 2, 2022
Next filing
Mar 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (Right to Buy) Award $0 +110K $0.00 110K Dec 21, 2023 Common Stock 110K $11.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the stock option shall vest and become exercisable on the first anniversary of December 21, 2023, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.